Aug. 30, 2021

Prof. Lietzen named Best Lawyer in America in FDA and Biotechnology & Life Sciences Law

Professor Erika Lietzan has again been named a “Best Lawyer in America”  in both FDA Law and Biotechnology & Life Sciences.  This marks the eighth year in a row for FDA Law and the fourteenth year in a row for Biotechnology Law.  The Best Lawyers honor is meant to identify the top 5 percent of attorneys in the United States, and it is based on the judgment of one’s peers.  Professor Lietzan practiced law for 18 years prior to joining the University of Missouri in 2014, including eight years as a partner in the Food and Drug group of Covington…

Jan. 14, 2021

Professor Lietzan elected as a member of the CREDIMI

Professor Erika Lietzan is a “Membre Associé” at the Centre de Recherche sur le Droit Des Marchés et des Investissements Internationaux (CREDIMI), which is part of the Faculty of Laws, Economics, and Politics of Dijon, within the University of Bourgogne in Dijon, France. The CREDIMI focuses on the study of the market, its functioning, and its players, including specific sectoral markets. Professor Lietzan works with specialists in drug law and health law at the CREDIMI. She has guest lectured to students, participated in conferences (both in Dijon and virtually), co-authored (e.g., in the Yale Journal of Health Policy, Law, and…